NKTR
Nektar Therapeutics · Healthcare
SVP, COO and CFO Gil M Labrucherie sold $316K of Nektar Therapeutics
Sold$316,391
$13.10Price
24,149Shares
−9%Stake
What NKTR did after the filing
- The stock from Thu, Nov 18 close, $176.40
- +16.2%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Jan 3 close.
Traded Tue, Nov 16. Filed Thu, Nov 18, 1:06 PM ET, during the session. Returns use the Nov 18 close and the Jan 3 close. Not investment advice.